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Background: Heart failure (HF) is a major public health problem due to its poor outcomes. Beta blockade (BB) is an established therapy in the 
treatment of HF. Some patients experience a subsequent left ventricular ejection fraction (LVEF) decline after an initial increase on BB. This study 
aimed to measure the frequency of LVEF decline after initial response to BB therapy in patients with non-ischemic cardiomyopathy (NICM).
Methods: Patients were included from the HF Clinic at AECOM with NICM and LVEF less than or equal to 40% and with an LVEF rise of greater than 
or equal to 5% after one year of BB. Post-response LVEF decline of greater than or equal to 5% to a final LVEF of less than or equal to 35% was 
evaluated. The modified Simpson’s Rule using 2D echocardiography was used to determine LVEF.
Results: 56 patients were included in the study. NICM patients with and without post-response LVEF decline are shown in the graph. A post-
response LVEF decline was observed in 16.1% of patients. The mean nadir LVEF of patients with post-response LVEF decline was 24.4 ± 3.0 at a 
mean interval of 3.9 ± 2.4 years after initial LVEF. The proportion of patients who experienced a post-response LVEF decline was not confounded by 
concomitant medications, ethnicity or gender.
Conclusion: A significant proportion (16.1%) of NICM patients whose LVEF increased over one year of BB experienced a subsequent LVEF decline. 
Ethnicity and gender did not predict differences in the proportion of patients with post-response LVEF decline.
